Description
T-peptide, a Tuftsin analog, can be used for the research of human immunodeficiency virus (HIV) infection. T-peptide prevents cellular immunosuppression and improves survival rate in septic mice. T-peptide also can inhibit the growth of residual tumor cells after surgical resection[1][2].—Cancer-programmed cell death–C92H171N45O18—-[1]Simpson DM, et, al. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology. 1996 Nov;47(5):1254-9.|[2]Gao YL, et, al. Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice. Sci Rep. 2015 Nov 18;5:16725.–2022956-62-1–2195.66—-O=C([V][Q]([V][Y]([R][R][R][R][R][R][R][R][R]N)[K])I)C–Cancer; Infection; Inflammation/Immunology–H2O–HIV;Microtubule/Tubulin—-Anti-infection;Cell Cycle/DNA Damage;Cytoskeleton–Peptides




Did you check our products for animal nutrition?